RESOURCES

Advancing Pulmonary Fibrosis: Preclinical Readouts in Mice Models

Gut Microbiome Integration in Drug Discovery and Development of Small Molecules

More than 30 international leading experts has developed proposals to facilitate integration of the microbiome in drug discovery and development.

Oncodesign Services x ZoBio – ITW

Follow our exciting story and stay tuned to witness the positive impact this union can have on research!

Phinc & Oncodesign Services

With Oncodesign Services and Phinc, unlocking the power of PBPK prediction and ADMET experimentation for a better drug development!

Advancing Drug Discovery through 3D Cell Models: Unveiling Novel Hits and Mechanisms

Discover our findings highlight the importance of 3D cell models in drug discovery. Download the poster!

Combitherapy in Preclinical Breast Cancer HR+/HER2- Models

Doublet and Triplet Combinations of Eribulin, Fulvestrant, and Palbociclib in Preclinical Breast Cancer Models

This study investigated in vivosynergism between eribulin and palbociclib in a breastcancer patient-derived xenograft (PDX) model.

Oncodesign Services Acquires ZoBio

Acquisition of ZoBio, a Dutch CRO expert in biophysics-based small molecule drug discovery, by Oncodesign Services.

Oncolytic Virus Research

Oncodesign Services has been working with ViraTherapeutics GmbH, an Austrian company and subsidiary of Boehringer Ingelheim, on their oncolytic viral immunotherapy since 2018.

Chemical, Biochemical, Cellular, and Physiological Characterization of Leucettinib-21, a Down Syndrome and Alzheimer’s Disease Drug Candidate

How to repurpose your cancer drug to a Molecular RadioTherapy drug candidate

In this blog, Dr Eftychia Koumarianou deals with the ground-breaking and intriguing approach that hides behind the theranostics.

Navigating from molecules to medicines in our chemistry department

Christophe Parsy, Ph.D, MBA, head of the medicinal chemistry team since 2020, presents his team's daily challenges and missions.